GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications

Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust

NASHVILLE, TENNESSEE / ACCESS Newswire / December 4, 2025 / GraphiteRx and Mark Cuban Cost Plus Drugs today announced an expansion of their partnership to power the Cost Plus Marketplace for Businesses (CPM), reinforcing a shared commitment to improving the availability of more affordable medications for hospitals, pharmacies, and clinics. By pairing Cost Plus Drugs' innovative pricing model with GraphiteRx's industry-leading marketplace platform, the continued collaboration supports a more modern pharmaceutical supply chain.

Addressing Key Medication Challenges

Delivering meaningful budget relief during heightened financial pressure
Healthcare customers continue to face severe financial strain. Through CPM, customers can save over 50% on many medications, helping budgets stretch further at a time when every dollar counts.

Improving availability of key drug products
The collaboration also enhances supply of essential medications, helping hospitals, pharmacies, and clinics secure these medications more reliably.

"We are proud to support healthcare providers who collectively serve over 40 million patients a year," said David Zilberman, Founder & CEO of GraphiteRx. "Our joint effort with Cost Plus Drugs helps them realize savings opportunities that aren't always available through traditional channels."

Platform Intelligence for Cost Visibility, Tracking, and Decision Support

GraphiteRx provides CPM tools that surface savings opportunities, track financial impact, and integrate with leading decision-support systems. This brings straightforward pricing insights directly into purchasing and clinical workflows, helping organizations make informed, cost-efficient medication decisions.

A Shared Vision for Greater Transparency

This extended partnership reflects a long-term commitment to building a more open, efficient and fair supply chain. Together, Cost Plus Drugs and GraphiteRx are focused on expanding the CPM platform to further reduce costs and strengthen access to essential medications.

"The healthcare system is full of opportunities for improvement and fixing it requires partners we can trust," said Mark Cuban, Co-Founder of Cost Plus Drugs. "GraphiteRx is helping make this vision a reality for customers nationwide."

About Mark Cuban Cost Plus Drugs

Mark Cuban Cost Plus Drugs is transforming the pharmaceutical industry by bringing transparency and affordability to drug pricing. The Cost Plus Marketplace provides hospitals, clinics, surgery centers, university health networks, pharmacies, and other healthcare providers with direct access to thousands of medications at significantly lower costs. For more information please visit: www.CostPlusDrugs.com.

About GraphiteRx

GraphiteRx powers commerce in healthcare and its mission is to increase access to and reduce the cost of healthcare. With its AI-powered pioneering marketplace, order management, and e-commerce solutions, GraphiteRx is revolutionizing the procurement and distribution of pharmaceuticals and medical supplies. For more information please visit: www.GraphiteRx.com.

SOURCE: GraphiteRx